Veterinary Medicines

MARFLOQUIN 100 MG/ML SOLUTION FOR INJECTION FOR BOVINES AND PIGS (SOWS)

Authorised
  • Marbofloxacin
Download as PDF

Product identification

Medicine name:
MARFLOQUIN 100 MG/ML SOLUTION FOR INJECTION FOR BOVINES AND PIGS (SOWS)
Quiflox 100 mg/ml šķīdums injekcijām liellopiem un cūkām
Active substance:
  • Marbofloxacin
Target species:
  • Cattle
  • Pig (sow)
Route of administration:
  • Intramuscular use
  • Subcutaneous use
  • Intravenous use

Product details

Active substance and strength:
  • Marbofloxacin
    100.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        3
        day
      • Milk
        36
        hour
      • Meat and offal
        6
        day
      • Milk
        72
        hour
    • Pig (sow)
      • Meat and offal
        4
        day
  • Subcutaneous use
    • Cattle
      • Meat and offal
        6
        day
      • Milk
        36
        hour
  • Intravenous use
    • Cattle
      • Meat and offal
        6
        day
      • Milk
        36
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01MA93
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Latvia
Package description:
  • Box of one 100 ml solution bottle for injection
  • Box of one 250 ml solution bottle for injection
  • Box of one 50 ml solution bottle for injection

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
  • Krka d.d. Novo Mesto
  • Virbac
Responsible authority:
  • Food And Veterinary Service
Authorisation number:
  • V/DCP/11/0016
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0223/002
Concerned member states:
  • Austria
  • Belgium
  • Czechia
  • Germany
  • Greece
  • Hungary
  • Italy
  • Latvia
  • Lithuania
  • Portugal
  • Slovakia
  • Spain

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 1/03/2024
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 1/03/2024
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 1/03/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."